Skip to content

AOCI at other companies

Schrodinger logo
SchrodingerSDGR
-$28K-131%
Recursion Pharmaceuticals, Inc. logo
Recursion Pharmaceuticals, Inc.RXRX
$26.66M+88.5%
Spyre Therapeutics, Inc. logo
Spyre Therapeutics, Inc.SYRE
-$767K-212%
AbCellera Biologics Inc. logo
AbCellera Biologics Inc.ABCL
-$2.42M+65.4%
AnaptysBio, Inc. logo
AnaptysBio, Inc.ANAB
-$146K-191%
Precigen logo
PrecigenPGEN
-$17K-242%

Other financials

Income statement

See full
Revenue$215.0K-81.8%
Operating income-$30.8M-11.2%
Net income-$29.6M-12.3%
EPS (diluted)-$0.19+9.5%

Balance sheet

See full
Cash & equivalents$9.7M-84.9%
Total debt$4.0M-37.2%
Total equity$172.0M-13.5%
Total assets$195.6M-15.9%

Cash flow

See full
Operating cash flow-$26.3M-20.5%
CapEx$30.0K+20.0%
Free cash flow-$26.3M-20.5%

Valuation

See full
Market cap$1.57B+43.6%
Enterprise value$1.57B+73.1%
P/S855.5×+628×

Profitability

See full
Operating margin-6,723%-14,525pp
Net margin-6,450.8%-13,699pp
FCF margin-5,365.2%-9,300pp

Returns & leverage

See full
Return on equity-63.9%+28.0pp
Debt / equity0.0×
Current ratio6.6×+0.9×

Where this comes from

Reported directly by Absci Corporation in its filing.

Tagged under the XBRL concept us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax.

The official record: Absci Corporation’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →

Ask your AI about Absci Corporation's aoci.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Absci Corporation's AOCI?
Absci Corporation (ABSI) reported AOCI of $304K in Q1 2026.
How has Absci Corporation's AOCI changed year-over-year?
Absci Corporation's AOCI increased by 1500.0% year-over-year, from $19K to $304K.
What does AOCI mean?
Accumulated gains and losses bypassing the income statement — unrealized investment gains/losses, currency translation, pension adjustments, and hedge results.